Martín D, Piulachs M D, Bellés X
Centro de Investigación y Desarrollo (CSIC), Barcelona, Spain.
Mol Cell Endocrinol. 1996 Aug 9;121(2):191-6. doi: 10.1016/0303-7207(96)03864-6.
Allatostatins with a typical YXFGL-amide C-terminus constitute a neuropeptide family, which was discovered because of its inhibitory action on insect juvenile hormone synthesis. In the search for possible new functions for allatostatins we focused our attention on the fat body. Our previous studies on the cockroach Blattella germanica suggested the occurrence of factors terminating vitellogenesis, and the hypothesis here was that allatostatins might be one of these factors. Our experiments have shown that allatostatin impaired vitellogenin release in fat bodies incubated in vitro, and that this effect appears to be mediated by the inhibition of vitellogenin glycosylation. Fluvastatin also inhibited vitellogenin release, and mevalonolactone counteracted the inhibitory effects of allatostatin. These results suggest that allatostatin acts upon the mevalonate pathway and synthesis of dolichol, which would explain the inhibition of vitellogenin glycosylation. We finally conclude that allatostatins may effectively contribute to the termination of the vitellogenic cycle in B. germanica.
具有典型YXFGL-酰胺C末端的咽侧体抑制素构成一个神经肽家族,该家族因其对昆虫保幼激素合成的抑制作用而被发现。在探寻咽侧体抑制素可能的新功能时,我们将注意力集中在脂肪体上。我们之前对德国小蠊的研究表明存在终止卵黄发生的因子,这里的假设是咽侧体抑制素可能是这些因子之一。我们的实验表明,咽侧体抑制素会损害体外培养的脂肪体中卵黄原蛋白的释放,并且这种作用似乎是由对卵黄原蛋白糖基化的抑制介导的。氟伐他汀也抑制卵黄原蛋白的释放,而甲羟戊酸内酯可抵消咽侧体抑制素的抑制作用。这些结果表明,咽侧体抑制素作用于甲羟戊酸途径和多萜醇的合成,这可以解释对卵黄原蛋白糖基化的抑制。我们最终得出结论,咽侧体抑制素可能有效地促成了德国小蠊卵黄发生周期的终止。